$NVDA stock fell 5% this week, according to our price data from Polygon.
It has been the most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $NVDA (you can track the company live on Quiver's $NVDA stock page):
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 155 times in the past 6 months. Of those trades, 0 have been purchases and 155 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- AJAY K PURI (EVP, Worldwide Field Ops) has made 0 purchases and 9 sales selling 1,000,000 shares for an estimated $183,002,962.
- MARK A STEVENS has made 0 purchases and 4 sales selling 794,182 shares for an estimated $142,193,969.
- DEBORA SHOQUIST (EVP, Operations) has made 0 purchases and 20 sales selling 309,840 shares for an estimated $56,186,171.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 99 sales selling 256,070 shares for an estimated $47,057,182.
- HARVEY C JONES sold 250,000 shares for an estimated $44,333,450
- DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 16 sales selling 109,986 shares for an estimated $20,556,412.
- AARTI S. SHAH has made 0 purchases and 3 sales selling 19,000 shares for an estimated $3,357,549.
- A BROOKE SEAWELL sold 12,728 shares for an estimated $2,341,117
- JOHN DABIRI has made 0 purchases and 2 sales selling 3,630 shares for an estimated $667,756.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$NVDA Hedge Fund Activity
We have seen 2,714 institutional investors add shares of $NVDA stock to their portfolio, and 2,523 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 589,595,243 shares (-75.1%) from their portfolio in Q4 2025, for an estimated $109,959,512,819
- J. STERN & CO. LLP added 124,849,603 shares (+13709.1%) to their portfolio in Q4 2025, for an estimated $23,284,450,959
- CARDANO RISK MANAGEMENT B.V. removed 70,049,522 shares (-89.7%) from their portfolio in Q1 2026, for an estimated $11,972,864,300
- VANGUARD GROUP INC added 43,149,475 shares (+1.9%) to their portfolio in Q4 2025, for an estimated $8,047,377,087
- SG AMERICAS SECURITIES, LLC removed 37,810,007 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $6,462,486,396
- JPMORGAN CHASE & CO removed 32,478,144 shares (-6.6%) from their portfolio in Q4 2025, for an estimated $6,057,173,856
- SOFTBANK GROUP CORP. removed 32,110,456 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,988,600,044
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 21 times in the past 6 months. Of those trades, 8 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE LIZZIE FLETCHER sold up to $15,000 on 04/08.
- REPRESENTATIVE DANIEL MEUSER has traded it 4 times. They made 0 purchases and 4 sales worth up to $60,000 on 03/25, 02/25, 01/30, 01/14.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 6 times. They made 3 purchases worth up to $80,000 on 03/13, 01/30, 11/18 and 3 sales worth up to $80,000 on 03/25, 12/24, 12/19.
- REPRESENTATIVE TIM MOORE sold up to $50,000 on 03/24.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 03/19.
- REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 01/30.
- REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 1 purchase worth up to $500,000 on 01/16 and 1 sale worth up to $5,000,000 on 12/24.
- SENATOR SHELDON WHITEHOUSE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/09.
- SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 11/21.
- SENATOR KATIE BOYD BRITT sold up to $15,000 on 11/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 24 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 03/31/2026
- Needham issued a "Buy" rating on 02/18/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
- Truist Securities issued a "Buy" rating on 12/29/2025
- Stifel issued a "Buy" rating on 12/29/2025
- Baird issued a "Outperform" rating on 12/26/2025
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 30 analysts offer price targets for $NVDA in the last 6 months, with a median target of $275.0.
Here are some recent targets:
- Cody Acree from Benchmark set a target price of $250.0 on 03/31/2026
- Kevin Cassidy from Rosenblatt set a target price of $325.0 on 03/23/2026
- C.J. Muse from Cantor Fitzgerald set a target price of $300.0 on 03/23/2026
- Srini Pajjuri from Raymond James set a target price of $323.0 on 03/19/2026
- William Stein from Truist Securities set a target price of $287.0 on 03/18/2026
- N. Quinn Bolton from Needham set a target price of $240.0 on 03/18/2026
- John Vinh from Keybanc set a target price of $275.0 on 03/17/2026
You can track data on $NVDA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
